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Abstract
Objective Safety concerns about the Riata ICD shock lead
were recently raised, with insulation failure due to conductor
externalisation. Its incidence and presentation were assessed,
and predictors of insulation failure and lead survival of the
Riata 1580–1582 were studied, retrospectively, before the
official recall.
Methods All 374 patients at the Erasmus Medical Center
between July 2003 and December 2007 with a 1580, 1581
or 1582 shock lead.
Results The majority of the patients were male (78 %), with a
median age of 60 years (IQR 52–70); primary prevention in
61 %. Median follow-up was 60.3 months (IQR 35.5–73.2),
with 117 (31 %) patients dying. Electrical abnormalities (main-
ly noise, 65 %) were observed in 20/257 patients (7.8 %).
Definite conductor externalisation was confirmed with fluoros-
copy or chest X-ray in 16 patients, and in one after extraction.
One patient presented with a drop in the high-voltage imped-
ance trend with a short circuit of the ICD system during
defibrillation testing, and needed to be shocked externally. In
8 more patients, conductor externalisation was found during an
elective procedure. No predictors of externalisation could be
found, except for the use of single coil (p00.02). Median time
to conductor externalisation was 5 years (IQR 3.1–6.2). Lead
externalisation was observed in 5.4 % (95 % CI 3.1–9.3) at
5 years and 22.7 % (95 % CI 13.6–36.6) at 8 years.
Conclusion A high incidence of insulation defects associated
with conductor externalisation in the Riata ICD lead family is
observed. The mode of presentation is diverse. This type of
insulation failure can lead to failure of therapy delivery.
Keywords Complications . ICD . Insulation defect .
Inappropriate therapy . Lead failure . Riata lead
Introduction
Implantable cardioverter defibrillators (ICDs) are implanted
for primary and secondary prevention of sudden cardiac
death in patients at high risk for life-threatening ventricular
arrhythmias [1]. The ICD has evolved from a large device
which needed abdominal implantation to a much smaller
device that can be implanted subcutaneously. Although
ICDs have become smaller, the device therapy possibilities
have become more sophisticated, from shock only to tiered
therapy. The defibrillator leads have also evolved from
epicardial patches to transvenous leads with even smaller
lead diameters due to changes in lead design [2]. However,
while the number of ICDs implanted still increases, this is
not paralleled with real technological advancement: ICD
longevity has decreased, and attention becomes more fo-
cused on other ICD and ICD lead-related problems [3, 4].
Malfunction of ICD components may lead to inappropriate
therapy or can even be involved in withholding appropriate
therapy, which may lead to life-threatening situations. The
defibrillator lead is the most fragile component of the ICD
system [5]. The number of complications increases with the
time that the lead is in place [5, 6]. Insulation failure is the
most frequent cause of lead failure, but lead fracture, loss of
capture, abnormal impedance and sensing failure can also
occur [5]. Recently, in the Medtronic Sprint Fidelis ICD
lead, failure was caused by a pace-sense conductor fracture
which led to lead failure in up to 8.5 % [7, 8].
We previously encountered changes in electrical parame-
ters in a patient implanted with a Riata 1580–1582 series ICD
lead (St JudeMedical, Sylmar, CA, USA), which were caused
by an insulation defect of the ICD lead with conductor
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externalisation [9]. This has led us to pay attention to all ICD
patients who have undergone an elective device-related pro-
cedure for such failure and as we increasingly saw similar
failures, in this study we aimed to assess the incidence and
mode of presentation of insulation failure of the St Jude Riata
1580, 1581 and 1582. We wanted to find predictors of con-
ductor externalisation and determine lead survival of the de-
fibrillator leads implanted at the Erasmus Medical Center. The
study describes our population before an official recall was
issued.
Methods
Study population
For the present study, all 374 consecutive patients implanted
with Riata ICD leads between July 2003 and December
2007 at the Erasmus Medical Center were included.
Defibrillator leads
The Riata 1580 and 1581 are dual-coil shock leads. The Riata
1582 is a single-coil shock lead. All are active fixation, true
bipolar, 8 French leads. The leads have a multi-lumen design
with symmetrically aligned cables in the lead body. Outer
insulation material is Dow Corning Q7-4780 silicone. Inner
insulation material surrounding the conductors is made of
ethylene tetrafluoroethylene (ETFE). The dual-coil leads
(1580 and 1581) have three lumina for the conductors that
are spaced equally around the inner coil. The single-coil lead
(1582) has two lumina opposite to one another.
Data collection and follow-up
Clinical data were obtained from patient records, procedural
records and our local ICD database. Follow-up for vital
status was 100 % complete at the administrative censoring
date of 30 November 2011. All patients underwent routine
device check-ups every 3 to 6 months except for patients
with home monitoring (every 6 to 12 months). Capture
thresholds, sensing amplitudes and pacing and shock im-
pedance were routinely measured and checked for abnormal
changes.
Statistical analysis
Normality of distribution was assessed using the Kolmogorov-
Smirnov test. Continuous variables were expressed as mean ±
SD, if normally distributed, otherwise by median and inter-
quartile ranges (IQR). Continuous data were analysed with
Student’s t test or Mann–Whitney U test, when appropriate.
Categorical data are expressed as number and percentage and
compared with the Chi-square test or Fisher’s exact test when
appropriate. Rates of externalised conductors were estimated
by life-table analysis with 95 % confidence intervals (CIs).
Univariate Cox proportional hazards analysis was performed
to identify those variables that significantly predicted lead
failure. The following covariates were predefined to enter the
model: age, gender, left ventricular ejection fraction, coronary
artery disease (CAD), type of device (i.e. single-chamber, dual-
chamber, or resynchronisation), and venous access site. Statis-
tical analysis was performed using Stata version 12 SE for
Windows (StataCorp, College Station, TX). A two-sided P
value of <0.05 was considered statistically significant.
Results
Clinical and technical characteristics
The study cohort consisted of 374 patients. The population
was predominantly male (78 %), with a median age of
60 years (IQR 52 to 70 years). The majority of patients
had New York Heart Association (NYHA) functional class
II (53 %), with a median left ventricular ejection fraction
(LVEF) of 27 % (IQR 21 to 33 %), and a median QRS
duration of 130 ms (IQR 106 to 166 ms). Further baseline
characteristics of the study patients are presented in Table 1.
During a median follow-up of 3.0 years (IQR 3.0 to 6.1),
117 patients (31 %) died and 15 patients (4 %) underwent
heart transplantation. Information on the leads of the trans-
plantation patients was available, so they were included for
lead survival analysis.
Table 1 Baseline characteristics of the study patients
n0374
Age (years) 60 (52–70)
Male gender 293 (78 %)
Follow-up (years) 5.0 (3.0–6.1)
Underlying heart disease
- Coronary artery disease 222 (59 %)
- Prior myocardial infarction 181 (49 %)
- Dilated cardiomyopathy 96 (26 %)
- Hypertrophic cardiomyopathy 13 (3 %)
NYHA class
- I 55 (15 %)
- II 199 (53 %)
- III-IV 117 (31 %)
Ejection fraction (%) 27 (21–33)
QRS duration (ms) 130 (106–166)
Indication type
- Primary prevention 227 (61 %)
- Secondary prevention 147 (39 %)
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Table 2 shows the technical aspects of ICD implantation.
A single-chamber ICD was implanted in 39 % of the
patients. The majority of implantations (95 %) were per-
formed on the left side. The venous access site was the left
cephalic vein in 59 %. Eighty percent of the patients re-
ceived a St Jude Riata 1580 shock lead.
Lead failure and mode of presentation
Seven patients developed device infection during follow-up
for which the ICD system was extracted (2 %). There were
no ventricular lead perforations or ICD malfunctions. Elec-
trical abnormalities were found during follow-up in 20 of
257 surviving patients (7.8 %) (Table 3). This was noise in
13 patients (65 %), sometimes accompanied by other elec-
trical defects. Inappropriate shocks occurred in 9 patients.
The other patients presented with a decrease in pacing or
high-voltage (HV) impedance, non-capture, or a decreased
sensing. One patient presented with a decrease in long-term
HV impedance trend. A defibrillation test was performed to
ascertain the integrity of the ICD system. During testing
there was a short circuit in the ICD which led to failure of
therapy delivery for which the patient needed external
defibrillation.
Conductor externalisation was confirmed with fluorosco-
py in 16 of the surviving patients (80 %). In 12 patients the
defect was also visible on chest X-ray. This was predomi-
nantly on the left lateral X-ray (Fig. 1). In 4 patients there
was no documented fluoroscopy or chest X-ray available.
The lead was extracted in 1 patient and conductor external-
isation was visible (Fig. 2), so that a total number of 17
patients had confirmed externalisation. In 1 patient there
was ‘bulging’ of the lead on the lateral chest X-ray, suggest-
ing a possible insulation defect. In the remaining 2 patients
data were insufficient.
These findings led to a meticulous search for conductor
externalisation in patients without electrical abnormalities
who underwent an elective device procedure, (i.e. elective
replacement or device upgrade). In 8 patients conductor
externalisation was found in this way during fluoroscopy
as performed during or before implantation (Table 4). This
was detectable on chest X-ray in only 3 out of 7 patients (no
chest X-ray available in 1 patient). In all patients the insu-
lation defect with conductor externalisation was proximal to
the distal RV shock coil at the level of the tricuspid valve or
lower right atrium. This means that we had in total 25
patients (9.7 %) with a conductor externalisation.
Outcome
In the 20 patients who presented with electrical abnormali-
ties, the lead was successfully extracted and replaced in 12
patients. It was returned to the manufacturer in 6 patients. In
5 patients an additional pace/sense lead was added. One
patient had an additional shock lead implanted. Extraction
was unsuccessful in one patient and a subcutaneous ICD
was implanted. The ICD was switched off at the explicit
wish of one patient.
In the 8 patients in whom the defect was discovered
during an elective procedure, 3 patients underwent extrac-
tion and replacement of the ICD lead. Four patients received
an additional ICD lead and the old lead was abandoned. In
one patient, the ICD was replaced with a home-monitoring
device as all electrical parameters were completely normal.
Time to conductor externalisation
Life-table analysis was performed to estimate the rate of
externalised conductors in Riata leads as function of service
time after implantation. The estimated rates of externalised
conductors are shown in Fig. 3. The rates of externalised
conductors were 5.4 % (95 % CI, 3.1 % to 9.3 %) and
22.7 % (95 % CI, 13.6 % to 36.6 %), at 5 and 8 years after
implantation, respectively. The median time to insulation
failure was 5.0 years (IQR 3.1 to 6.2 years).
Predictors of conductor externalisation
Univariate Cox proportional hazards analysis could not
identify any covariate significantly associated with conduc-
tor externalisation, except for a low LVEF (p00.04). The
Table 2 Technical characteristics
n0374
Device
- Single chamber 145 (39 %)
- Dual chamber 103 (28 %)
- CRT 126 (34 %)
Side of implantation
- Right 17 (5 %)
- Left 357 (95 %)
Venous access
- Left cephalic vein 222 (59 %)
- Right cephalic vein 5 (1,5 %)
- Left subclavian vein 134 (36 %)
- Right subclavian vein 12 (3 %)
- Left axillary vein 1 (0.5 %)
Lead
- Single coil
- 1582 30 (8 %)
- Dual coil
- 1580 301 (80 %)
- 1581 43 (12 %)
CRT cardiac resynchronisation therapy
Neth Heart J (2013) 21:127–134 129
T
ab
le
3
L
ea
d
de
fe
ct
s
pr
es
en
tin
g
w
ith
el
ec
tr
ic
al
ab
no
rm
al
iti
es
G
en
de
r
A
ge
(y
ea
rs
)
L
ea
d
P
re
se
nt
at
io
n
In
ap
pr
op
ri
at
e
sh
oc
k
In
te
rv
al
E
xt
er
na
lis
at
io
n
on
fl
uo
ro
sc
op
y
E
xt
er
na
lis
at
io
n
on
ch
es
t
X
-r
ay
A
P
L
L
A
ct
io
n
R
em
ar
ks
1
M
71
15
80
N
oi
se
N
o
24
89
Y
es
Y
es
N
o
Y
es
E
xt
ra
ct
io
n
2
M
52
15
80
N
oi
se
Y
es
70
5
Y
es
Y
es
N
o
Y
es
P
/S
le
ad
ad
de
d
3
M
70
15
80
N
oi
se
Y
es
25
42
Y
es
Y
es
N
o
Y
es
IC
D
sw
itc
he
d
of
f
4
F
61
15
80
N
oi
se
Y
es
23
80
Y
es
Y
es
Y
es
Y
es
E
xt
ra
ct
io
n
5
M
61
15
82
N
oi
se
Y
es
14
05
Y
es
Y
es
Y
es
Y
es
E
xt
ra
ct
io
n
6
F
34
15
82
N
oi
se
,
no
pa
ci
ng
Y
es
15
60
N
A
N
o
P
/S
le
ad
ad
de
d
N
ea
r
bu
lg
in
g
7
M
66
15
80
N
oi
se
Y
es
15
41
N
A
N
o
P
/S
le
ad
ad
de
d
8
M
62
15
80
N
oi
se
N
o
10
76
N
A
N
o
E
xt
ra
ct
io
n
E
xt
er
na
lis
ed
9
M
50
15
80
H
V
im
pe
da
nc
e
↓
N
o
13
62
Y
es
Y
es
N
o
Y
es
E
xt
ra
ct
io
n
IC
D
fa
ils
du
ri
ng
D
F
T
10
M
56
15
82
N
oi
se
/T
W
ov
er
se
ns
in
g
Y
es
10
15
Y
es
Y
es
N
o
Y
es
E
xt
ra
ct
io
n
S
ty
le
t
bl
oc
ks
11
F
69
15
81
N
oi
se
Y
es
12
14
Y
es
N
A
E
xt
ra
ct
io
n
12
M
55
15
80
P
ac
in
g
im
pe
da
nc
e
↓
N
o
26
24
Y
es
N
o
S
ho
ck
le
ad
ad
de
d
13
F
52
15
82
S
en
si
ng
↓
N
o
16
16
Y
es
N
o
ex
tr
ac
tio
n
14
F
56
15
80
N
oi
se
Y
es
15
99
Y
es
Y
es
N
o
Y
es
E
xt
ra
ct
io
n
15
M
56
15
80
P
ac
in
g
im
pe
da
nc
e
↓
N
o
28
14
Y
es
Y
es
N
o
Y
es
E
xt
ra
ct
io
n
16
F
48
15
80
H
V
im
pe
da
nc
e
↓
N
o
30
56
Y
es
Y
es
N
o
Y
es
E
xt
ra
ct
io
n
17
F
55
15
81
N
on
-c
ap
tu
re
N
o
19
57
N
A
N
o
P
/S
le
ad
ad
de
d
In
su
ff
ic
ie
nt
da
ta
18
M
69
15
81
N
on
-c
ap
tu
re
N
o
12
64
Y
es
Y
es
N
o
Y
es
F
ai
le
d
ex
tr
ac
tio
n
S
-I
C
D
19
M
46
15
80
N
oi
se
/T
W
ov
er
se
ns
in
g
N
o
28
54
Y
es
Y
es
N
o
Y
es
P
/S
le
ad
ad
de
d
20
M
21
15
82
N
oi
se
N
o
81
3
Y
es
N
o
E
xt
ra
ct
io
n
A
P
an
te
ro
-p
os
te
ri
or
,
D
F
T
de
fi
br
ill
at
io
n
th
re
sh
ol
d
te
st
in
g,
F
fe
m
al
e,
H
V
hi
gh
vo
lta
ge
,
L
L
la
te
ro
-l
at
er
al
,
M
m
al
e,
N
A
no
t
av
ai
la
bl
e,
T
W
T
w
av
e,
P
/S
pa
ce
-s
en
se
,
S-
IC
D
su
bc
ut
an
eo
us
IC
D
130 Neth Heart J (2013) 21:127–134
use of single-coil leads was borderline significant (p00.06).
It was the only remaining significant variable in multivariate
analysis with a HR of 4.4 (95 % CI 1.2–15.8; p00.02).
Discussion
The aim of this study was to describe the incidence and mode
of presentation of insulation failure, to assess predictors of
lead failure and determine lead survival of the St Jude Riata
1580, 1581 and 1582 leads implanted at the Erasmus Medical
Center. The main findings of this study are that insulation
failure with conductor externalisation is more frequent than
previously described and that the mode of presentation is not
uniform and can even be without electrical abnormalities. No
predictors of insulation damage with externalised conductors
could be found, except for the use of a single-coil Riata.
Incidence of conductor externalisation
A large retrospective study in more than 15 thousand patients
implanted with Riata 1580 and 7000 series combined showed
insulation damage in 0.21 % of the patients [10]. A report by
St Jude from December 2010 mentions an insulation abrasion
rate of 0.47 % over 9 years of use [11]. This number was
revised in the product information update in November 2011
to 0.63% all-cause abrasion rate, with externalised conductors
in 15 % of these cases [12]. Single-centre studies reported
insulation defects in 0.13 % up to 2 % of the patients [13, 14].
We found conductor externalisation in more than 9 % of the
patients.
The reported company numbers are based on data
reported to St Jude and on leads returned for analysis. Not
all leads are extracted and returned to the manufacturer. This
may lead to an underestimation of the actual number of this
type of insulation defect. Recent abstracts are more in line
with our data, and suggest Riata failure rates of 8–15 %
including leads that are electrically intact but exhibit extern-
alised conductors. The leads may function electrically nor-
mally if the insulation that covers the pace-sense and high
voltage cables is intact [15].
Location of insulation defect
Usually, insulation defects occur in the pocket due to abra-
sion of the lead by the ICD, at the level of lead fixation, in
the vasculature or heart due to lead to lead abrasion, or at the
level of the clavicle [16]. The location of the insulation
defect in this study was proximal to the distal shock coil at
the level of the tricuspid valve and lower right atrium in all
patients. This was also reported by others [9, 14, 17]. Hauser
et al. describe that leads with inside-out abrasion frequently
also display multiple insulation defects distributed along the
length of the lead [18]. Local abrasive forces from neigh-
bouring myocardial structures (i.e. movement of the tricus-
pid valve) may play a role in causing insulation breach in
this type of lead [14, 19]. Another explanation may be
inside-out abrasion caused by movement of the conduc-
tors within the insulation leading to conductor external-
isation through the outer insulation material as was
shown by analysis of the returned leads by St Jude in
85 %. The remaining 15 % were due to external sources
of abrasion [12]. Further, it is tempting to believe that
leads implanted with more ‘slack’ leading to excessive
movement develop more insulation defects at this partic-
ular site.
Mode of presentation
Insulation defects in general may present with oversensing
and undersensing, loss of capture, and changes in pacing or
high-voltage (HV) lead impedance. Previous studies on the
Riata lead have reported noise and inappropriate shocks as
mode of presentation [9]. Also, a rise in pacing impedance and
threshold has been described [17, 20–22].
Fig. 1 At the left: lateral view; fluoroscopic image of an externalised
conductor in patient 9 (which led to a defect ICD after a high-voltage
shock). At the right a lateral view with enlargement of a lead segment
which is near normal. This patient had an electrical defect with noise,
and could no longer be paced
Fig. 2 Segment of the lead showing 4 externalised conductors which
had abrased the outer isolation
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Based on review of returned leads, St Jude reports
pacing or HV impedance changes in 37 %, inappropriate
therapy in 36 %, noise and oversensing in 18 % and a
rise in threshold in 9 % as mode of presentation [12].
The mode of presentation of this type of insulation
defect is also not uniform in this study. It ranges from
a change in pacing or HV impedance, to noise with
inappropriate therapy, to non-capture and even decreased
sensing.
A large study in the FDA medical device database
reports impedance changes and sensing problems as
most frequent modes of presentation, followed by pac-
ing problems [23]. Conductor externalisation can also be
present without changes in electrical parameters. The
latter is particularly worrisome as this leaves the patient
unknown to the physician and potentially unprotected.
Normal electrical findings may be present if the inner
ETFE insulation layer of the conductors is still intact. A
study, however, reports breached ETFE insulation in
21 % of the returned leads with normal electrical find-
ings in 6 %. This shows the magnitude of the problem.
In patients with normal electrical findings, there may be
externalisation of the conductors with still intact or even
with breached ETFE insulation [24].
It remains unknown when or if this layer of insulation
will eventually break and what will happen when the con-
ductors are exposed to blood and excessive movement with-
out the protective silicone layer. St. Jude reports there are no
data to support that externalised conductors will fail or pose
a mechanical or anatomical threat [25]. The latter is con-
firmed by Hauser et al., but the former is in contrast with the
patient in our study with the short circuit. This was also
detected by other investigators [20]. Another study con-
ducted by Hauser and coworkers shows that Riata and Riata
ST leads are prone to high voltage failure that has resulted in
death. None of these failures could be attributed to external-
ised conductors [18]. It requires further investigation in our
study population to ascertain the cause of death in the
patients who died during follow-up. To our opinion, the
integrity of the system can therefore not be counted on. As
the mode and time of presentation is so diverse, and even
sometimes without a change in electrical parameters, the
system should be checked extensively when there is only
the slightest suspicion of a lead problem and maybe even on
a routine basis
Fluoroscopy and chest X-ray
This study shows that the findings of insulation defect
and conductor externalisation can be so subtle that they
cannot always be detected on a chest X-ray. An expla-
nation may be lack of resolution or the phase of the
cardiac cycle in which the image is made. The images
are still and made in full inspiration, which leads to a
non-physiological situation. Fluoroscopy images are
moving and made during normal respiration. Therefore,
fluoroscopy should always be performed and especially
from different angles and magnification to check the
Table 4 Lead defects discovered at the time of elective device procedure
Gender Age Lead Presentation Inappropriate
shock
Interval Externalisation
on fluoroscopy
Externalisation
on chest X-ray
AP LL Action Remarks
1 M 56 1580 ERI No 2062 Yes No Extraction
2 M 44 1581 ERI No 1962 Yes NA Extraction failed,
ICD lead added
Stylet blocks
3 M 54 1580 ERI No 1848 Yes No ICD lead added
4 M 58 1580 TW oversening Yes 942 Yes No Extraction
5 F 63 1580 upgrade No 2057 Yes Yes Yes Yes ICD lead added
6 M 23 1582 ERI No 1882 Yes Yes No Yes Extraction
7 M 68 1580 ERI No 2215 Yes Yes Yes No ICD lead added
8 M 68 1580 ERI No 1813 Yes No No No Home monitoring Normal
electrical
parameters
AP antero-posterior, ERI elective replacement indication, F female, LL latero-lateral, M male, NA not available, TW T wave
Fig. 3 Proportion of externalised conductors as appearing over time
with 95 % confidence intervals
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integrity of the insulation [20]. Using only standard
fluoroscopy projections may lead to underdetection of
the insulation defect.
Time to insulation failure
Kleemann and co-workers showed that estimated ICD lead
survival was 85 % and 60 %, 5 and 8 years, respectively,
after implantation. They also showed that the annual failure
rate increased progressively over time after implantation and
was associated with multiple implanted leads.5 The time to
insulation failure of the Riata lead in our study was 5.0 years
(IQR 3.1 to 6.2 years). However, a patient with a Riata 1570
lead with an insulation defect was reported only 4 months
after implantation [20].
Predictors of lead failure
Predictors of insulation failure could not be found in this
study. This may be due to the small number of patients. A
recent report by Erkapic et al. found that non-ischaemic
cardiomyopathy was an independent univariate predictor
of this type of insulation failure [14]. We can confirm the
observation that single-coil leads are more susceptible to
inside–out abrasion.
Limitations
Fluoroscopy was only performed in patients who were
scheduled for an elective device procedure or in patients
who had electrical abnormalities or noise. The incidence of
insulation defect may be underestimated or overestimated.
Selection and observer bias may have played a role since we
are now focused on this problem with this type of lead.
Conclusion
This observational retrospective study shows that the inci-
dence of insulation damage in Riata 1580–1582 ICD leads is
higher than previously described. The mode of presentation
of the insulation defect is not uniform, although in the
majority of cases it presented with noise. However, insula-
tion defects were also seen at routine fluoroscopy screening
at the time of elective box change without noise or changes
in electrical parameters. Therefore a more structured ap-
proach to patients with this type of lead is needed. Routine
chest X-ray cannot exclude an insulation defect. In patients
with Riata 1580, 1581 or 1582 leads, careful fluoroscopic
evaluation of the RV defibrillation lead from multiple angu-
lations should be considered, especially at the time of ICD
generator exchanges or when there is an unexpected change
in interrogation data.
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